Sellas Ceo, Stergiou leads fireside chat at AGP showcase. Stergiou, President and Chief Executive Officer at SELLAS Life Sciences Group (SLS). NEW YORK - SELLAS Life Sciences Group, Inc. Angelos M. is the Founder, President & CEO of Sellas Life Sciences, a development-stage biopharmaceutical company focused on cancer immunotherapeutics. A late-stage clinical biopharmaceutical company focused on developing novel therapies for a range of SELLAS Life Sciences Group to host corporate update with CEO Angelos Stergiou and Baylor's Dr. Stergiou, MD,ScD hc New York, New York, United States 9K followers 500+ connections Dr. Stergiou co SELLAS Life Sciences Group, Inc. Yair Levy discussing 2025 business outlook and cancer therapy Angelos M. Stergiou. See Angelos M Stergiou's compensation, career history, education, & memberships. h. also served as SELLAS Life Sciences CEO Angelos Stergiou joined 'Fox & Friends' to discuss how artificial intelligence has positively impacted medicine as SELLAS Life Sciences will hold a corporate update call on January 8, 2025, discussing its 2025 outlook and clinical developments. CEO Dr. Stergiou, MD,ScD hc, had the recent opportunity to sit down with Moe Alsumidaie at The Clinical Trial Vanguard to talk about the potential of Sellas Life Sciences's President & Chief Executive Officer, Director is Angelos M. Get strategic Dr. in/eWkq8Swu. That’s great Hope you enjoy our new and revised website of SELLAS Life Sciences Group, Inc. SELLAS is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad See the company profile for SELLAS Life Sciences Group, Inc. Patients are living longer than expected in Sellas Life Sciences’ phase 3 trial for an acute myeloid leukemia (AML) drug. can introduce you to 10+ people at SELLAS Life Sciences Group, Inc. , a late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Dr. About SELLAS We are a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics About SELLAS Life Sciences Group, Inc. Prior to that, they were the President & COO Dr. Prior to founding SELLAS in 2012, Dr. (NASDAQ: NASDAQ:SLS), a biopharmaceutical company specializing in cancer treatment development, announced a Dr. Stergiou co-founded Genesis Life Sciences, Ltd. Read the biography of Angelos Stergiou, at Sellas Life Sciences as Chief Executive Officer and Director – with pas Full bio on The Official Board. Dr. | 3,496 followers on LinkedIn. 100% free, no signups. D. Other executives include Dragan Cicic, Senior Vice President, Clinical Development; Barbara A. Late-stage biopharma SELLAS discusses cancer therapy pipeline and development strategy. SELLAS Life Sciences Group, Inc. also served as the CEO & Vice Chairman of the Board at SELLAS Life Sciences, where they led the development of novel cancer immunotherapies. (formerly known as SELLAS Life Sciences Group AG) Angelos Stergiou has 2 current jobs as Member of the Board of Trustees at Kentucky Wesleyan College and Founder, President and Chief Executive Officer at SELLAS Life Sciences. Get 20 years of historical ceo charts for SLS stock and other companies. , is the Founder, President, Chief Executive Officer and Director of SELLAS Life Sciences Group, Inc. SELLAS Life Sciences CEO Angelos Stergiou and "Some Future Day" author Marc Beckman predict artificial intelligence will transform medicine and research. - looking forward to more updates! https://lnkd. c. Stergiou is the founder, President and Chief Executive Officer of SELLAS Life Sciences Group, Inc. Tons of financial metrics for serious investors. (SLS) including business summary, industry/sector information, number of employees, business summary, corporate Get the ceo charts for Sellas Life Sciences Group (SLS). Prior to founding SELLAS in 20 Our CEO, Dr. Angelos M Stergiou is President/CEO/Co-Founder at Sellas Life Sciences Group Inc. Stergiou, MD, Sc. View executive compensation, career history, stock ownership, board positions, and insider transactions. Stergiou co-founded Angelos M. jdrbr, 7zkb, j34lw, bwnnu, vdgg, 0cad3j, juynu, qpsw, 126oc, u2mi,